Re:Alzheimer’s Drug Sharply Slowed Cognitive Decline
by jonlucc on Friday March 20, 2015 @09:21PM
(#9241540)
I'm pretty sure if they add efficacy endpoints to Phase I, it becomes a Phase I/Phase II and the efficacy is for Phase II. The other problem with efficacy in Phase I is that alzheimer's efficacy is not measured over such short time frames.
[ Parent
| on HN ]
There are no comments on this comment yet.